Skip to content
Menu

Wells Fargo Upgrades Zimmer Biomet Holdings to Overweight, Raises Price Target to $123

Benzinga Newsdesk 15 hours ago

Analyst RatingsNewsUpgradesPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Wells Fargo analyst Larry Biegelsen upgrades Zimmer Biomet Holdings (NYSE:ZBH) from Equal-Weight to Overweight and raises the price target from $113 to $123.

Wells Fargo analyst Larry Biegelsen upgrades Zimmer Biomet Holdings (NYSE:ZBH) from Equal-Weight to Overweight and raises the price target from $113 to $123.

Read at benzinga.com